Doximity Revenue

In the fiscal year ending March 31, 2026, Doximity had annual revenue of $644.86M with 13.05% growth. Doximity had revenue of $145.37M in the quarter ending March 31, 2026, with 5.12% growth.

Revenue (ttm)

$644.86M

Revenue Growth

+13.05%

P/S Ratio

6.20

Revenue / Employee

$732,799

Employees

880

Market Cap

4.00B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	644.86M	74.46M	13.05%
Mar 31, 2025	570.40M	94.98M	19.98%
Mar 31, 2024	475.42M	56.37M	13.45%
Mar 31, 2023	419.05M	75.50M	21.98%
Mar 31, 2022	343.55M	136.65M	66.05%
Mar 31, 2021	206.90M	90.51M	77.76%
Mar 31, 2020	116.39M	30.69M	35.82%
Mar 31, 2019	85.70M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Teladoc Health	2.51B
Privia Health Group	2.25B
Tempus AI	1.36B
HealthEquity	1.34B
Omnicell	1.23B
Waystar Holding	1.16B
Hinge Health	646.34M
10x Genomics	638.78M

Revenue Rankings

DOCS News

3 days ago - Doximity downgraded to Underperform from Buy at BofA - TheFly
7 days ago - Doximity price target lowered to $26 from $28 at JPMorgan - TheFly
22 days ago - Doximity management to meet virtually with Piper Sandler - TheFly
27 days ago - Did Five Below, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
6 weeks ago - Doximity to Present at the William Blair 46th Annual Growth Stock Conference - Business Wire
6 weeks ago - Cisco upgraded, Doximity downgraded: Wall Street’s top analyst calls - TheFly
7 weeks ago - Doximity downgraded to Equal Weight from Overweight at Barclays - TheFly
7 weeks ago - Barclays downgrades Doximity on slowing industry growth - TheFly

More News